10 febrero 2015
An experimental medication that targets a protein in Ebola virus called VP24 protected 75 percent of a group of monkeys that were studied from Ebola virus infection, according to new research.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Qd7kLh0dMd0/150210103411.htm
